Skip to content

Comparison of Etomidate-Fentanyl and Propofol -Fentanyl sedation in patients scheduled for colonoscopy

Comparison of Etomidate-Fentanyl and Propofol -Fentanyl sedation in patients scheduled for colonoscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201212195381N4
Enrollment
80
Registered
2013-01-07
Start date
2012-07-30
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with intestine diseases who need colonoscopy. disease of intestine,unspecified

Interventions

Intervention 1: Fentanil 1microgram/kg and bolus dose of propofol 0.5 mg/kg was given, followed by continuous infusion at 25microgram/kg/min. Intervention 2: Fentanil 1 microgram/kg intravenously and
Treatment - Drugs
Fentanil 1 microgram/kg intravenously and bolus dose of etomidate 0.1 mg/kg was given,followed by a continuous infusion at5microgram/kg/min

Sponsors

Vice-chancellor of Research Babol University Of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:patients scheduled for comlete elective colonoscopy;ages of 18-55 years;ASA I-II. exclusion criteria:History of large bowel surgery;pregnancy;patients with psychiatric and emotional disorder;history of addiction;history of allergic reaction;history of pulmonary and metabolic disorders.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: Before of discharge. Method of measurement: Visual Analogues Scale.

Secondary

MeasureTime frame
Drug adverse effects. Timepoint: Before and after colonoscopy. Method of measurement: Before and after colonoscopy.;Colonoscopist satisfaction. Timepoint: After colonoscopy. Method of measurement: Numerical rating scale for colonoscopist satisfaction.;Blood pressure. Timepoint: Every 5 minutes. Method of measurement: Noninvasive cuff measurrment.;Heart rate. Timepoint: Every 5 minutes. Method of measurement: Pulse counting.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Nadia Banihashem

Babol University of Medical Sciences

nbanihashem@yahoo.com+98 11 1223 8296

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026